Showing results (201-210 of 223) with videos related to

Sort By:
Pageof 23
Neurology and Therapy|November 2, 2024
Factors and Reasons Associated with Hesitating to Seek Care for Migraine: Results of the OVERCOME (US) StudyRobert E Shapiro, Eva Jolanda Muenzel, Robert A Nicholson, et al.
Cephalalgia : an International Journal of Headache|June 14, 2023
Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and careAubrey Manack Adams, Dawn C Buse, Elizabeth Leroux, et al.
Pain and Therapy|September 19, 2025
Opioid Use among People with Migraine: Results of the OVERCOME (US) StudySait Ashina, Elizabeth Johnston, E Jolanda Muenzel, et al.
Headache|September 27, 2019
Does Mindfulness-Based Cognitive Therapy for Migraine Reduce Migraine-Related Disability in People with Episodic and Chronic Migraine? A Phase 2b Pilot Randomized Clinical TrialElizabeth K Seng, Alexandra B Singer, Christopher Metts, et al.
Advances in Therapy|January 12, 2026
The Role of Income and Health Insurance on Migraine Care: Results of the OVERCOME (US) StudyRichard B Lipton, Betzaida Martinez, Dawn C Buse, et al.
Neurology. Clinical Practice|September 6, 2021
Response to Mindfulness-Based Cognitive Therapy Differs Between Chronic and Episodic MigraineElizabeth K Seng, Alexandra B Conway, Amy S Grinberg, et al.
Drug Development and Industrial Pharmacy|August 4, 2006
Development and preliminary experience with an ease of extractability rating system for prescription opioidsN P Katz, D C Buse, S H Budman, et al.
Headache|February 1, 2017
Psychological Factors Associated With Chronic Migraine and Severe Migraine-Related Disability: An Observational Study in a Tertiary Headache CenterElizabeth K Seng, Dawn C Buse, Jaclyn E Klepper, et al.
Neurology|January 17, 2024
Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life: Results of the OVERCOME (US) StudyRobert E Shapiro, Robert A Nicholson, Elizabeth K Seng, et al.
Headache|April 25, 2022
Evaluating the clinical utility of the patient-identified most bothersome symptom measure from PROMISE-2 for research in migraine preventionRichard B Lipton, Peter J Goadsby, David W Dodick, et al.
Pageof 23